Afinitor 2.5 mg, 5 mg and 7 mg tablets had a market value of roughly $412 million over the last four quarters, according to IQVIA.
House Democrats have secured multiple policy changes in the USMCA, including those related to prescription drug pricing,
Amgen's biosimilar Avsola offers a biological treatment option to patients across critical disease states, including chronic inflammatory conditions.
Diplomat and OptumRx's combination will expand the innovative specialty pharmacy and infusion solutions that OptumRx can offer.
Pharmacy technology and automation companies are stepping up to the plate to ensure that pharmacists can juggle their roles successfully.
Exjade had a market value of roughly $113 million and Jadenu had a market value of about $470 million for the most recent 12 months ended in September.
Kinnect is a transformational on-site pharmacy option for community health centers, which offers mental health and addiction services.
The FDA has approved three applications for first generics of Novartis’ Gilenya (fingolimod) capsules for relapsing forms of multiple sclerosis in adult patients.
Blink Health is offering new patients more than 4,000 medications for free.
Amneal has received the Food and Drug Administration’s clearance for three generics that it is introducing immediately, including the first generic of Carafate (sucralfate oral suspension).
Hydrocortisone valerate cream 0.2% had a market value of roughly $11.5 million, according to IQVIA September 2019 data.
Vishal Arora and Nitin Shingate are joining RxSense as chief technology officers for its enterprise and consumer divisions, respectively.
Erlotinib has a market value of approximately $150 million annually, according to sales data.
The Exelon Patch and its generics had a market value of $161 million for the 12 months ended Sept. 30, 2019.
Cumberland's RediTrex injection is a treatment for adult and pediatric patients with rheumatoid arthritis, as well as adults with psoriasis.
Flu shots are available seven days a week at CVS Pharmacy and MinuteClinic locations nationwide.
Mylan's Ogivri is available in 420 mg multidose vials and 150 mg single-dose vials.
Zejula is now the only, once-daily PARP inhibitor approved as monotherapy treatment for recurrent ovarian cancer beyond those with a BRCA mutation in both the recurrent maintenance and late-line treatment settings.
The FDA has approved a new antibacterial drug to treat complicated UTIs.
The FDA has approved Xcopri, a new treatment for adults with partial-onset seizures.
Hectorol injection single-dose vials and multidose vials brand and generics had a market value of approximately $138 million for the most recent 12 months ending in September 2019, according to IQVIA.
Arakoda, the first antimalarial product approved by the Food and Drug Administration for the prevention of malaria, is being made available at select pharmacies and wholesalers.
As part of an international collaboration, the FDA has approved AstraZeneca's new treatment option for patients with chronic lymphocytic leukemia.
SingleCare's Drug Basket feature helps consumers get the lowest prices for prescription drugs at nearby pharmacies.
Novartis’ Adakveo is the first targeted therapy to treat patients with a painful complication of sickle cell disease.
Alnylam’s Givlaari has been approved by the FDA to treat a genetic disorder the causes buildup of toxic porphyrin molecules, which are formed during the production of heme.
Customers can access pharmacy services from Walgreens, CVS, Walmart, Kroger and Rite-Aid via Propeller Health's app.
Zydus Cadila's generic Otezla provides a treatment for psoriatic arthritis, and mouth sores for people with Behcet's disease.
Potassium chloride for oral solution, 20 mEq, had a market value of roughly $90 million, according to IQVIA data from September 2019.
The NACDS Foundation will present its Excellence in Patient Care Award to Janice Pringle and Judy Rosser.
Pfizer plans to launch Humira biosimilar in 2023.
Upsher-Smith has added Zembrace SymTouch injection to its savings program for patients
Public quality standards set forth by USP increased competition in the generic medicines market and reduced overall prescription drug costs by $11 billion in 2015 and 2016.
Schnucks customers can donate to The Salvation Army campaign by choosing to round up their purchase to the nearest dollar.
BeiGene USA's Brukinsa provides a treatment for patients with relapsed and refractory mantle cell lymphoma
Mutual Drug and PerceptiMed have entered a strategic alliance to bring the scripClip will-call solution to Mutual Drug's network pharmacies.
Bartell's is teaming up with The Salvation Army and WARM 106.9 to bring toys to local children.
In detailed letters to 15 Medicaid program directors. NACDS called for action on policy recommendations designed to help prevent opioid abuse and addiction, while caring for those in pain.
Fresenius Kabi's generic Emend provides clinicians with a treatment alternative that has a 24-month shelf life.
A group of investors led by Greg Wasson, former Walgreens Boots Alliance CEO will acquire a majority stake in Innovation Associates.
After 21 years, Miles White is stepping down as Abbott’s CEO next March. The company has named Robert Ford as his successor.
Diplomat's Q3 revenue was comprised of $1.2 billion from the company’s specialty segment and $82 million from its pharmacy benefit manager segment
Tarceva and its generics had a market value of approximately $145 million during the year ended Sept, 30, 2019.
Bartell's, which introduced NimbleRx for prescription delivery early this year, is launching Instacart.
Eli Kalif will join Teva as executive vice president and chief financial officer on Dec. 22.
The Viatris name will be effective upon closing of the combination of Mylan and Upjohn, which is expected to occur in mid 2020.
Private equity firm KKR has reportedly been preparing a proposal to take Walgreens Boots Alliance private.
Epiduo gel had a market value of about $33.7 million for the 12 month period ended September 2019, according to IQVIA.
The Rite Aid Foundation's $75,000 donation to the American Red Cross will be divided to help relief efforts in Northern and Southern California.
Foamix and Menlo’s merger will result in a combined company focused on the dermatology space.
Fresenius Kabi is expanding its heparin and Simplist prefilled syringe portfolio with the addition of a small-volume presentation of Heparin.
Celgene’s Reblozyl is the first therapy to treat patients with a rare blood disorder.
Schnucks’ curbside pickup service is now available at stores across Missouri, Illinois, and Indiana.
In an SEC filing on Nov. 6, CVS signaled its intention to close 22 underperforming retail pharmacy stores in the first quarter of 2020.
On Nov. 11, more than 90,000 meals are expected to be provided to veterans and active-duty military at more than 265 Hy-Vee stores.
Cardinal Health’s first-quarter revenue was $33.4 billion. Despite being 6% greater than revenue in the same quarter last year, it was accompanied by a 3% drop in profit.
The terms of Mallinckrodt's sale of BioVBectra were updated since it was initially announced, with the final total at nearly $250 million.
Teva and Celltrion's Truxima is the first biosimilar to Genentech’s Rituxan (rituximab).
It’s 4 p.m. at the CVS Pharmacy on Main Street in New City, N.Y.
RedHill's Talicia is the first and only FDA approved rifabutin-based H. pylori infection therapy.
With the FDA approval of Ziextenzo — a biosimilar of Neulasta — Sandoz is the first and only company to offer long- and short-acting filgrastim biosimilar treatment options.
Sanofi’s Fluzone High-Dose Quadrivalent is used in people age 65 and older, to protect against influenza A and B strains.
CVS has initiated residential drone delivery of prescriptions via UPS Flight Forward, from a CVS pharmacy in North Carolina.
Lupin's levothyroxine sodium tablets now is approved as a generic of Synthroid, Unithroid, and Levoxyl.
Paul Campanelli has been named Endo chairman of the board, and will continue as president and CEO until a successor is appointed.
Generic Bentyl is Camber's first injectable product to hit the market.
President Trump will nominate Stephen Hahn, chief medical executive at The University of Texas MD Anderson Cancer Center, as FDA commissioner.
Hy-Vee will match customer donations up to $100,000, during its seventh annual Hy-Vee Homefront Round Up this month.